Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Average: 2017-2024

Historic Equity Average for Collegium Pharmaceutical (COLL) over the last 8 years, with Dec 2024 value amounting to $212.1 million.

  • Collegium Pharmaceutical's Equity Average rose 12.45% to $253.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $253.5 million, marking a year-over-year increase of 12.45%. This contributed to the annual value of $212.1 million for FY2024, which is 8.71% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Equity Average stood at $212.1 million for FY2024, which was up 8.71% from $195.1 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Equity Average ranged from a high of $212.1 million in FY2024 and a low of $136.7 million during FY2020.
  • In the last 3 years, Collegium Pharmaceutical's Equity Average had a median value of $198.9 million in 2022 and averaged $202.1 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Equity Average soared by 52.76% in 2020, and later decreased by 1.88% in 2023.
  • Collegium Pharmaceutical's Equity Average (Yearly) stood at $136.7 million in 2020, then skyrocketed by 42.23% to $194.5 million in 2021, then grew by 2.27% to $198.9 million in 2022, then declined by 1.88% to $195.1 million in 2023, then rose by 8.71% to $212.1 million in 2024.